|
Recent Developments |
|
03-OCT-16
Wanbury, largest producer of Metformin API and leading exporter of Tramadol API, announced that the company announces successful completion of USFDA inspection at its API facility in Patalganga Plant, Maharashtra.
26-SEP-13
Wanbury announced that the company's manufacturing facilities at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2015(12) | 31-Mar-2014(12) | 31-Mar-2013 (12) | | Net sales | 4837.54 | 4193.81 | 4114.98 | | Other Income | 64.88 | 54.60 | 45.49 | | Total Income | 4902.42 | 4248.41 | 4160.47 | | Cost of goods sold | 4584.23 | 3911.52 | 3981.67 | | OPBDIT | 318.19 | 336.89 | 178.80 | | PAT | -2569.92 | -98.09 | -254.69 | | Gross Block | - | - | - | | Equity capital | 199.69 | 199.69 | 173.79 | | EPS (Rs.) | - | - | -14.65 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 6.5 | 7.9 | 4.3 | | Net margin (% of OI) | -52.4 | -2.3 | -6.1 |
|
|
Detailed Financials
|
|
|
|
|
